License Agreement

Related by string. License Agreements * licenses : DRIVING WHILE LICENSE REVOKED / Agreements : User Agreement * License Agreement SPLA . Getty Images License Agreement . Patent License Agreement . Exclusive License Agreement . Signs License Agreement . Sign License Agreement . License Agreement EULA . Announces License Agreement . Trademark License Agreement *

Related by context. All words. (Click for frequent words.) 80 Licensing Agreement 72 Licence Agreement 72 Collaboration Agreement 71 Distribution Agreement 70 Patent License Agreement 69 Supply Agreement 68 Agreement 65 Purchase Agreement 64 Acquisition Agreement 63 Commercialization Agreement 63 Joint Venture Agreement 63 License Agreements 62 Asset Purchase Agreement 62 License Option Agreement 61 sublicense 60 Agreements 60 Lease Agreement 60 Option Agreement 60 Termination Agreement 59 licensing agreements 59 Assignment Agreement 59 Reseller Agreement 59 Settlement Agreement 59 Teaming Agreement 59 Exclusive License Agreement 58 Distributor Agreement 58 Definitive Agreement 58 Stock Purchase Agreement 58 Amended Agreement 58 Exclusivity Agreement 57 Exclusive License 57 Standstill Agreement 57 Affiliation Agreement 57 Licensing Agreements 57 Cross License Agreement 57 Loan Agreement 57 Sponsorship Agreement 57 Sublicense Agreement 57 Distributorship Agreement 57 Definitive Agreements 57 Master License Agreement 56 Securities Purchase Agreement 56 LOI 56 Confidentiality Agreement 56 Licensing Deal 56 Letter Agreement 56 Transfer Agreement 56 Representation Agreement 55 Forbearance Agreement 55 Announce Licensing 55 Exclusive Licensing Agreement 55 Distribution Agreements 54 Supply Agreements 54 agreement 54 Participation Agreement 54 Partnership Agreement 54 Definitive Merger Agreement 54 Cooperation Agreement 53 Merger Agreement 53 License Pact 53 binding Letter 53 Worldwide Licensing Agreement 53 Development Agreement CRADA 53 Binding Agreement 53 Amending Agreement 53 Term Sheet 53 Amalgamation Agreement 53 Subscription Agreement 53 Share Purchase Agreement 53 Exclusive Distribution 53 Strategic Alliance 52 Binding Letter 52 Agreement SEDA 52 Cross Licensing Agreement 52 Combination Agreement 52 Signs Licensing Agreement 52 Formal Agreement 52 Acacia Subsidiary Enters 52 CRADA 52 Contract 52 Subsidiary Enters 52 Settlement Agreement Regarding 52 Waiver Agreement 51 Signs Licensing 51 MOU 51 Distribution Pact 51 Licensing Pact 51 Consent Judgment 51 Framework Agreement 51 Sign License Agreement 51 sublicenses 51 Trademark License Agreement 51 Purchase Agreements 51 Signs License Agreement 50 Contribution Agreement 50 Licence Agreements 50 Escrow Agreement 50 forbearance agreement 50 Modification Agreement 50 Announces License Agreement 50 sublicensed 50 definitive agreement 50 Patent Licensing Agreement 50 Leases 50 farmout agreement 50 Farmout Agreement 50 Milestone Payments 50 Exclusivity 50 Option Deed 50 Sublicense 50 Enters Into Joint Venture 50 agreements 50 Purchase Option Agreement 49 Settles Patent Litigation 49 InterfeRx 49 Misonix Announces 49 agreementwith 49 Commitment Letter 49 Sign Licensing Agreement 49 Settlement Agreements 49 Implementation Agreement 49 Restated Agreement 49 Confidentiality Agreements 49 Inks Licensing Deal 49 Option Agreements 49 Joint Venture 49 Acquires Exclusive 49 Announces Licensing Agreement 48 Announce Licensing Agreement 48 Exclusivity Period 48 Interconnection Agreement 48 Clinical Trials Agreement 48 Tolling Agreement 48 Financing Agreements 48 Credit Agreement 48 WSPP 48 farmin agreement 48 Signs Definitive 48 Obtains License 48 Permanent Injunction 48 Subscription Agreements 48 intent LOI 48 Property Option Agreement 48 License Agreement EULA 48 Enters Into Licensing Agreement 48 Formal Option Agreement 48 sublicensing 48 Joint Venture Agreements 48 Patent Covering 48 Subsidiary 48 Announce License Agreement 48 Osiris retains 47 Non Binding Letter 47 Definitive Option Agreement 47 definitive agreements 47 Arrangement Agreement whereby 47 Arbitration Proceeding 47 Value Added Reseller Agreement 47 Files Patent Application 47 Material Transfer 47 Formal Agreements 47 Underwriting Agreement 47 Lease Agreements 47 Receives Milestone Payment 47 sublicensee 47 Announce Exclusive 47 LoI 47 Transfer Agreements 47 Receives Patent 47 Polysilicon Supply Agreement 47 Agreement JOA 47 Implementation Deed 47 Joint Venture Agreement JVA 47 Cooperation Agreements 47 Purchase Agreement dated 47 theagreement 47 Promissory Note 47 Zor Pharmaceuticals 47 nonexclusive license 47 Arrangement Agreement 47 Farmout 47 NQCI 47 Anti Kickback Act 47 Patent Portfolio 47 Milestone Payment 47 Amended Option Agreement 47 Signs Binding Letter 46 Current Merger Agreement 46 Regains Nasdaq 46 Purchase Order 46 Consent Agreement 46 Acacia Subsidiary 46 Concession Agreement 46 CollaRx GENTAMICIN SURGICAL IMPLANT 46 Announce Collaboration Agreement 46 TVI Subscription Agreement 46 Extends Collaboration 46 Settles Litigation 46 MorphoSys proprietary 46 SpeBio joint venture 46 Initiates Clinical 46 Enters Into 46 Secures Patent 46 Inks Agreement 46 Announces Definitive Agreement 46 wholly owned subsidiary 46 License Application 46 GMP Certificate 46 Receives Confirmation 46 Wafer Supply 46 Committed Equity 46 exclusive sublicense 46 Final Judgment 46 Enters Into Definitive 46 BioElectronics Corporation Announces 46 Secures Exclusive 46 Definitive Purchase Agreement 46 Second Amended 46 Enters Into License Agreement 46 Merger Transaction 46 Settle Litigation 46 JHP Pharmaceuticals LLC 46 Taiho Pharmaceutical 46 Signs Agreement 46 sub licensable 46 Stipulation 46 Securities Purchase Agreements 46 Patent Infringement Litigation 46 Exclusive Licensing 46 exclusive distributorship 45 Develop Novel 45 License 45 Patent Portfolios 45 Inks Exclusive 45 Obtains Exclusive License 45 Biomarker Study 45 Consent Order 45 Receives NASDAQ 45 Mutually Agree 45 Enters Into Partnership 45 POTELLIGENT R Technology 45 Clearford Announces 45 Offtake Agreement 45 Amends Agreement 45 contractual agreements 45 Obtains Exclusive Rights 45 SRL Biovail 45 Daiichi Suntory Pharma 45 Restated Promissory Note 45 Conditional Approval 45 EULA 45 Modem Card 45 Completes Asset 45 Intent LOI 45 parties hereto 45 Signs Option Agreement 45 exclusive licensor 45 Stock Purchase Agreements 45 Arrangement MFA 45 Franchise Agreements 45 Patent Infringement Suit Against 45 Underlying Option Agreement 45 Files IND 45 Anti CD# Antibody 45 Seikagaku Corporation 45 Enters Agreement 45 Power Purchase Agreement 45 Tenancy Agreement 45 binding Memorandum 45 Milestone Payment From 45 Exclusive Licensee 45 Share Repurchase Plan 45 Licensor 45 Subsidiary Enters Into 45 Announce Merger Agreement 45 Enters Into Strategic 45 Intellectual Property Rights TRIPs 45 Enters Into Collaboration 45 Completes Reverse Merger 45 Voluntary Surrender 45 binding LOI 45 Xing Yang Security 45 CIP TRAMADOL ER 45 Inks Multi 45 Inks Pact 45 Issued Patent 45 InvaGen 45 commercialize telaprevir 45 Inks License 45 Reaches Agreement 45 exclusivity clause 45 Licenses Patents 45 Receives Notification 45 Registered Trademark 45 intercreditor agreement 45 Synerx 45 Submits Application 45 Permanent Injunction Against 45 definitive merger 45 Memorandum 45 Patent Issued 45 WiNet System 45 Enter Into 45 Signs Agreements 45 Contracts 44 Enters Strategic 44 sublicensing agreements 44 Licenses 44 Galderma SA 44 Safeguards Agreement 44 Announce Joint Venture 44 Expand Relationship 44 Begins Shipment 44 Expands Distribution 44 Settle Patent Litigation 44 Announces FDA Clearance 44 Terminates Agreement 44 Revolving Credit Agreement 44 Submits IND 44 Patent Dispute 44 Senior Secured Credit 44 contract 44 Renews Exclusive 44 Final Judgments 44 Stock Repurchase Plan 44 Credit Facility 44 Handok Pharmaceuticals 44 resolves patent infringement 44 OMJPI 44 Patent Infringement Lawsuit Against 44 upfront payment 44 Nippon Kayaku 44 Receives CE Marking 44 Achieves Milestone 44 HSR Waiting Period 44 Signs Long Term 44 Completes Patient Enrollment 44 Enters Into Agreement 44 Joint Venture JV 44 royalty payments 44 Royalty Payments 44 Official Licensee 44 Ongoing Connected Transactions 44 Elan Pharma 44 Enters Into Long Term 44 Norgine BV 44 Loramyc ™ 44 Consent Decree 44 Jointly Announce 44 licensee 44 irrevocable perpetual 44 Standby Equity Distribution 44 Enters Into Exclusive 44 ACACIA ACAC TECH 44 Ucyclyd Pharma Inc. 44 Option Grants 44 lease 44 Farmin Agreement 44 Patents Covering 44 supplemental indentures effecting 44 Inks Supply 44 Announces Definitive Merger 44 Material Definitive Agreement 44 Amended 44 Enters Joint Venture 44 Sign Definitive Merger 44 Patent Licensing 44 licensor 44 ZBx 44 Recapitalization Agreement 44 Investigational Device Exemption 44 nonexclusive 44 Production Sharing Agreement EPSA 44 Receives FDA Approvable 44 Inks Licensing Agreement 44 Earns Milestone Payment 44 Miraculins Announces 44 Licenses Novel 44 Entered Into 44 Flamel Technologies Announces 44 Global Reseller Agreement 44 MoU 44 BioSante Pharmaceuticals Announces 44 Monitoring Agreement EUMA 44 Stipulated 44 BSD License 44 Asset Purchase Agreements 44 Intergovernmental Agreement 44 Gets FDA Clearance 44 noncompetition agreement 44 Registered Trademarks 44 End User 43 Mentor Protege Agreement 43 Amends Revolving Credit 43 Collaborators Publish 43 Signs Lease 43 Summary Judgment Motions 43 Option Agreement dated 43 Enter Into Definitive 43 Kwang Dong 43 NFLPA Collective Bargaining 43 Inc. OTC TOFS 43 Enters Exclusive 43 Initiates Enrollment 43 Executes Agreement 43 Settle Patent Lawsuit 43 Tripartite Agreement 43 Tri Brid Engine Electric/Flex-Fuels/H2O 43 PROCAPS 43 Signs LOI 43 Regains Full 43 NMP# ® 43 Signs Multiyear 43 Signs Joint Venture 43 Receives Complete Response 43 Use Thereof 43 Prometheus Laboratories 43 BioZone 43 Proposed Arrangement 43 DOE USEC 43 Reverse Takeover 43 Nasdaq Listing Requirements 43 Announces Termination 43 Therapeutic Competitors Report 43 Enters Into Letter 43 Files Patent 43 NASDAQ Listing Requirements 43 Orapred ODT 43 DIP Loan 43 Definitive Acquisition 43 POTELLIGENT R 43 licensing 43 Acquisition Proposal 43 Taglich Brothers Initiates Coverage 43 Abbotly 43 Terminates Merger Agreement 43 Oncolys 43 AnGes 43 GenWay Biotech 43 PROLACRIA ™ 43 Monetizes 43 Marketing Authorisation 43 patented ASNAP TM 43 Testosterone Gel 43 FDA Accepts 43 OTCBB NVDL 43 Executes Letter 43 Nycomed GmbH 43 Inks Distribution 43 TRX1 43 Supplemental Indentures 43 Multimillion Dollar Contract 43 Receives Commitment 43 Pennsaid R 43 TRIPs Agreement 43 patent EP# 43 perpetual irrevocable 43 Enters Into Definitive Agreement 43 Expedited Review 43 Settle Patent Dispute 43 Regains NASDAQ 43 Reseller Partnership 43 DARA logo 43 Special Protocol Assessment 43 Discontinues 43 exclusivity 43 OTCBB FNXC 43 Torii Pharmaceutical 43 BioSyent Pharma 43 COMPLETE XRM 43 Closes Merger 43 Therapeutic Competitors Companies 43 Equipment Deals 43 NASDAQ Delisting 43 Announce Interoperability 43 Receives Orphan Drug 43 Option Joint Venture 43 Announce Signing 43 Portola Pharmaceuticals Inc. 43 Mutual Recognition Procedure 43 Closes Financing 43 pediatric exclusivity 43 Achieves Significant 43 VIVITROL ® 43 contractual arrangements 43 Financing Facility CEFF 43 Receives Funding 43 Patent Infringement Case 43 Oral Calcitonin 43 contractual clauses 43 Boroo Stability Agreement 43 VNUS patents 43 Signs Binding 43 Urocidin TM 42 Option Agreement whereby 42 Through Glycoscience ® 42 Initiates Dosing 42 Code# [001] 42 Pooling Agreement 42 Annette Bening Tom Hanks 42 Strategic Relationship 42 Forms Joint Venture 42 Levucell 42 CCI Pellet Agreements 42 Terminates Letter 42 GTC NASDAQ GTCB 42 supplemental indentures 42 Inc. OTCBB BTIM 42 No. RE# [001] 42 Subsidiary Arrangements 42 Java Specification Participation 42 Signs Exclusive 42 subsidiary Biovail Laboratories 42 Articulation Agreement 42 Controlled Deployment 42 Dwango Co. 42 ThyroTec LLC 42 Lescarden 42 Contract Renewal 42 Confirms Commitment 42 Expands Scope 42 Indenture 42 Receives Notice 42 Announce Agreement 42 Flagship Product 42 Secures Financing 42 Reports Receipt 42 Patents Issued 42 Approves Share Repurchase 42 Patent Lawsuit 42 Subsidiary Signs 42 Completes Acquisitions 42 Pending Litigation 42 OTCBB APCSF 42 Convertible Note 42 Indentures 42 Ceragenix 42 Resale Registration Statement 42 Nasdaq HALO 42 Nippon Shinyaku 42 Digital Rectal Massage 42 Completes Financing 42 Awarded Patent 42 S2 Therapeutics 42 Initiates Phase II 42 Tanabe Seiyaku 42 Time Warp patent 42 Files Patents 42 Derma Sciences Announces 42 ProQuin XR 42 Cease Trade Orders 42 HFTA 42 Fortical ® 42 Signs Distribution 42 Agree ment 42 Due Diligence Period 42 Arrangement Agreement pursuant 42 sublease 42 Computing EUC 42 Voluntary Cleanup 42 BioOne Corporation 42 Acceptable Use 42 Receives FDA Clearance 42 Patent Infringement Lawsuit 42 mutually acceptable definitive 42 Diamyd Medical Diamyd 42 Fresenius Biotech 42 Contingent Value Rights 42 Renews Long Term 42 ANDA filer 42 Patent Infringement Action 42 Completes Merger 42 Acquisition 42 forbearance agreements 42 Amalgamation Agreement dated 42 Licensee 42 Inc. QWIPTECH holds 42 Signs MOU 42 Placing Agreement 42 Exclusive Distributorship 42 Extend Partnership 42 No. #.# 42 wholly ownedsubsidiary 42 Renews Multi 42 Exploration Permit Application 42 Inks Long Term 42 Signs Merger Agreement 42 Receives Approval 42 Extend Relationship 42 GPSi Asia 42 VirnetX patents 42 Daewoong 42 Intractable Hiccups 42 exclusive licensee 42 Finalizes Agreement 42 Gene Expression Analysis 42 Genpharm 42 developing biomedical countermeasures 42 Receives Fast Track 42 MOSAID patents 42 definitive documentation 42 refusal ROFR 42 Secured Facility 42 Announce Definitive Merger 42 Announces Tentative Approval 42 Forges Partnership 42 Enters Into LOI 42 Tenancy Agreements 42 EyeTel 42 Obtains Patent 42 JSPA 42 convertible debenture 42 Forbearance Agreements 42 Proposed Acquisition 42 EPC Contract 42 Ariad patent 42 Announce Collaboration 42 Early Termination 42 Master Reseller 42 Stipulated Order 42 Hydromer 42 Patent Upheld 42 Patent Infringement 42 Million Dollar Contract 42 Complete Merger 42 Proposed Qualifying Transaction 42 Proposed Amalgamation 42 Agreements FTA 42 Patent Infringement Suit 42 Orphan Designation 42 Enters Into Distribution 42 Software Developer Kit 42 Aphthasol 42 Signs Contract 42 Unregulated Fishing 42 Not Disclosed 42 Marketing Authorization 42 VaxImmune 42 OTC SLUP 42 Gestiva TM 42 Expands Availability 42 Creative Commons Attribution 42 CEFF financings subject 42 Patent Nos. #,#,# #,#,# 42 Jacada Signs 42 Secures Long Term 42 OTC ZEGERID 42 Sign Definitive Agreement 42 Acquire Assets 42 Collaborates With 42 Terminate Merger Agreement 42 Expand Collaboration 42 Issues Shareholder 42 mutually terminated 42 Lease Renewal 42 NASDAQ CGEN announced 42 RNAi Therapeutics 41 tramiprosate ALZHEMED TM 41 Captisol 41 NBA NBPA Anti 41 Signs Multi 41 Complies 41 BioGeneriX 41 Beta Testing 41 Patents 41 MSc Qualified Person 41 Company TSX.V HLS 41 TSX SHQ 41 Patent Reexamination 41 Bupropion HCl ER 41 Performance Incentive Plan 41 Boot Camp Beta 41 Nasdaq IDEV 41 Awarded Patents 41 Arbitration Proceedings 41 International SRL BLS 41 Announces Initiation 41 Lease 41 Debt Settlement Agreements 41 rolling Biologics License 41 Dispute Resolution Policy 41 Nutra Pharma Announces 41 BioWa 41 seeking declaratory judgment 41 Acquirer Company 41 Plea Agreement 41 Receives Favorable 41 Therapeutic Antibody 41 Signs Memorandum 41 Order Granting 41 NASDAQ DRRX 41 Renews Agreement 41 www.nano 41 Biovail Laboratories 41 VITAGEL 41 Visual Voicemail patents 41 Purchase Agreement SPA 41 Enters Beta 41 Secures Contract 41 Listings Policy 41 Further Validates 41 FDA Okays 41 Concession Agreements 41 indemnifications 41 Surplus Contract 41 Fast Track Designation 41 Awarded Multi 41 Metals PINKSHEETS SREH 41 HHSN#C 41 costless collar 41 Terminate Agreement 41 Systemic Delivery 41 Receive Milestone Payment 41 CYOE 41 Merger Sub 41 Gentamicin Surgical Implant 41 Presents Preclinical Data 41 Helicos BioSciences Announces 41 Resolves Dispute 41 Application Programming Interface 41 No. HHSN#C 41 Dynepo TM 41 convertible promissory note 41 PDS PDS 41 Cabilly patent 41 Provides Update Regarding 41 Compulsory License 41 Servicing Agreement 41 Agreement CPA 41 invalid unenforceable 41 NewSight 41 Accelerated Share Repurchase 41 Subordination Agreement 41 RYZOLT TM 41 Holodniy 41 NASDAQ Deficiency Notice 41 submitted Biologics License 41 Signs Definitive Agreement 41 Convertible Promissory Note 41 Jointly Offer 41 commercialize Aganocides 41 Announce Early Termination 41 Enters Into Negotiations 41 Default Announcement 41 Extend Collaboration 41 Granted Orphan Drug 41 AGPLv3 41 Presents Positive Preclinical 41 Announce Partnership 41 Roaming Agreement 41 exclusive revocable 41 Acquire Controlling Interest 41 mutually satisfactory definitive 41 DPA countermeasures 41 Updates Shareholders 41 Forges Strategic 41 SF Lease 41 Corporation Nasdaq ACTG 41 Announces Private Placement 41 Commercialize 41 TRANSDUR ™ 41 DIP financing facility 41 Engages CHF Investor Relations 41 Exploitation Concession 41 Protiva Biotherapeutics 41 acne impetigo 41 Requisite Consents 41 sanofi aventis EURONEXT SAN 41 commercialize AzaSite 41 Dendritic Nanotechnologies Inc. 41 Progenitor Cell 41 Lodsys patents 41 Signs Non Binding 41 Biomarin 41 Implantable Medical 41 DURECT 41 Joint Stipulation 41 FAR Clause #.#-# 41 TRIPS Agreement 41 Captisol ® 41 Restructures Debt 41 Patent Broadly Covering 41 Reexamination Certificate 41 Declaratory Judgment 41 Recapitalization Transaction 41 Repurchase Agreement 41 Stock Repurchase Program 41 Restate Financials 41 Key Milestones 41 Receives Tentative Approval 41 Study Validates 41 Inc. OTCBB BOCL 41 Reclamation Permit 41 Announce Commencement 41 Agensys subsidiary 41 Transdermal Drug 41 Infringement Case 41 agreemen 41 Enters Into Settlement Agreement 41 Amends Terms 41 LFRP 41 Fovea Pharmaceuticals 41 Third Supplemental Indenture 41 Ark. Sup 41 Relaunches Website 41 Sole Source 41 Agreement DR CAFTA 41 Original Equipment Manufacturer OEM 41 tradename 41 Asset Sale 41 Paragraph IV Certification 41 Announce Expanded 41 Zcom Networks Announces 41 Reach Settlement Agreement 41 Awarded GSA Schedule 41 Megapharm Ltd. 41 ALDA announces 41 Inc.announced 41 Announces Proposed Acquisition 41 Fanotech 41 Patent Suit 41 Broadens Its 41 Galenea 41 Wholly Owned Subsidiary 41 Successfully Integrates 41 Share Purchase Agreements 41 Color Additives 41 Submits NDA 41 Completes Enrollment 41 Settle Patent 41 Preliminary Injunction Order 41 rPA Anthrax Vaccine 41 La.Code Civ.P. art 41 #,#,# warrants exercisable 41 Inks Deal 41 OTC EGIL 41 Terminates Contract 41 Presents Positive 41 Completes Previously Announced 41 Restructures Operations 41 Idenix Novartis 41 Strategic Partnership 41 commercialize taliglucerase alfa 41 Files Registration Statement 41 Streamlines Operations 41 Tostrex 41 www.vialicensing.com 41 Consummates 41 Repurchase Program 41 Regains Compliance 41 Asset Swap 41 Commencement Date 41 GPLv2 license 41 Orphan Drug Status 41 Kurt Cobain likeness 41 Files Provisional 41 FAST InStream TM 41 NYSE Amex BTX 41 Stock Incentive Plan 41 Participation Agreements 41 Inc. OTCBB BLEW 41 Previously Announced Private Placement 41 Justsystem 41 Receives Regulatory 41 NanoTherapies 41 Files Shelf Registration Statement 41 '# patents 41 Releases Upgraded 41 sublicense agreements 41 Co Branded 41 Announces Debt Settlement 41 AIMMS 41 Receives Tentative FDA 41 Biosearch 41 Fast Track Status 41 Revolving Credit Facility 41 Enters Negotiations 41 Files Trademark 41 commercialize Dimebon 41 Reaches Settlement Agreement 41 Zeatin 41 Syntonix 41 Settles Patent Dispute 41 ORADUR ® 41 Patent Lawsuit Against 41 Exercises Option 41 Convertible Debenture 40 Eniluracil 40 Proposed Merger Agreement 40 FDA Orphan Drug 40 Expands Internationally 40 Reimbursement Agreement 40 Medigen 40 Shelf Registration Statement 40 Reacquires 40 Production Sharing Agreement 40 OTCBB YCKM 40 Cavitation Technologies 40 Cellgate Inc. 40 Licence 40 Azur Pharma 40 Engine Oxygenator 40 Tectane Technologies Corporation 40 agrement 40 Awarded GSA 40 MyScreen PINK SHEETS MYSL 40 Strengthens Position 40 Argatroban 40 outlicensed 40 Discreet Certified 40 Receives Positive 40 Credit Facilities 40 Preferred Stock Purchase Agreement 40 EMD Biosciences Inc. 40 Inks LOI 40 Synerx Pharma 40 Order Approving 40 PharmaBio 40 Stockholders Approve Merger 40 SCO Unix copyrights 40 Antibody Discovery 40 Provides Shareholder 40 copromotion 40 License Agreement SPLA 40 OTC BGMO 40 User Agreement 40 ASNAP 40 Recombinant Protein 40 Treaty PCT 40 CEFF 40 Exclusion Order 40 Ampligen r 40 Finjan patents 40 Scheduling Order 40 Mundipharma 40 Secured Promissory Note 40 Obtains Exclusive 40 Copyright Infringement 40 MGM MIRAGE Hospitality 40 EHT AGN 40 MSON 40 Uracyst R 40 joint venture 40 patents 40 Receives Conditional 40 Inc. AMEX CTT 40 Production Sharing Contract 40 Handok 40 Enters Into Multi 40 USOTC SSWC 40 Delivers Next Generation 40 DIP Financing Facility 40 InterDigital patents 40 promissory note 40 Inc. OTCBB CYGX 40 FRN Support 40 Mircette R 40 Photodisinfection System 40 FDA Clears 40 Bayer Yakuhin 40 TM MMP Portfolio 40 Private Placement Offering 40 JAK2 Inhibitor 40 Commences Subsequent 40 Subcontract 40 Initiates Clinical Trial 40 #.#-# Instructions 40 Furthers Its 40 Highly Concentrated 40 Receives Shareholder Approval 40 EpiTherapeutics 40 consent decree 40 Ink Deal 40 symbol ABBI 40 Inks Deal With 40 ImmunoGen maytansinoid TAP 40 Tokyo JCNN 40 GRAS Status 40 Director Shareholding 40 Announces Intent 40 Nuvio trademark 40 TSX VENTURE GXG 40 TKM Ebola 40 Hyperion Catalysis International 40 PentaStaph 40 Patent Troll 40 Aptamer 40 Strengthens Balance Sheet 40 Merger Agreement pursuant 40 codevelop 40 Submits Supplemental 40 Outsourcing Contract 40 CORLUX CORT # 40 Rescission 40 Generic Version 40 trust indenture 40 Product Designation 40 DermaSphere R Technology 40 Successful Completion

Back to home page